« Back
Home /
Dacomitinib

Dacomitinib

Item no.	M1869-10mg
Manufacturer	AbMole
CASRN	1110813-31-4
Amount	10mg
Category	Oncology Neuroscience Neural Signaling Inhibitors & Compound Libraries Small Molecules By Organ Skin Cancer Breast Cancer
Type	Inhibitors
Specific against	other
Purity	0,9974
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	PF-00299804
Similar products	Dacomitinib, PF-00299804
Available
Molecular Weight	469, 94
Solubility	DMSO ≥ 25 mg/mL
Bioactivity information	Dacomitinib (PF-00299804) is an oral, irreversible, small molecule inhibitor of human epidermal growth factor receptor-1, -2, and -4 tyrosine kinases.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

M1869-10mg-safety-datasheet.pdf